Most clinical trials have a diversity problemClinical trial research helps scientists, doctors and patients understand whether drugs and devices are safe and effective. ACE inhibitors had been studied in clinical trials, but those trials had so few black patients that it wasn’t clear whether the risk was significant. “When I started doing my clinical trials, I had a white coordinator, I had a Hispanic coordinator and I had an African-American coordinator,” Rice noted. Regardless of the extra hurdles, increased participation among minorities is critical for improving clinical trials’ accuracy. “We can’t afford to be reticent when it comes to including a diverse patient population in clinical trials,” Ogedegbe said.

Source: Huffington Post February 23, 2017 12:56 UTC